Medtronic (NYSE:MDT) said today it is contributing a contemporary art sculpture to be placed in Medtronic Plaza outside the Minnesota Vikings’ U.S. Bank Stadium. The 25 foot tall, 107 foot long statue, named “The Horn” consists of 2 flowing ribbons, with inside surfaces polished like mirrors to reflect the faces of viewers. The company said the spiral […]
Medtronic
Appeals court upholds Medtronic’s win in patent spat with doc inventor
A federal appeals court yesterday upheld a win for Medtronic (NYSE:MDT) in a patent dispute over its CoreValve aortic valve replacement with inventor Dr. Troy Norred, according to legal filings. The physician’s 2013 patent infringement lawsuit, filed in the U.S. District Court for Kansas, was stayed until a trio of inter partes reviews by the U.S. Patent & Trademark Office’s […]
HRS 2016 roundup: Leadless pacers at the fore
Medtronic (NYSE:MDT) and St. Jude Medical (NYSE:STJ), aiming to distinguish their respective leadless pacemaker offerings, presented new data last week in San Francisco at the Heart Rhythm Society’s annual meeting. St. Jude said a subset of data from the Leadless II trial showed that its Nanostim device was was successfully retrieved in 14 patients up to 3.2 years after implantation, […]
Correction: Federal appeals court denies Endotach in Medtronic stent graft patent case
CORRECTION May 9, 2016: This article originally stated that the appeals court ruled against Medtronic. A federal appeals court today upheld a U.S. Patent & Trademark Office decision invalidating a stent patent licensed to Endotach, a subsidiary of patent troll Acacia Research, in its patent battle with Medtronic (NYSE:MDT). Endotach sued Medtronic in 2012, alleging that the medtech giant infringed a […]
Wright Medical COO, ex-Tornier CEO Mowry, steps down | Personnel Moves May 5, 2016
Wright Medical COO, ex-Tornier CEO Mowry, steps down Wright Medical (NSDQ:WMGI) said yesterday its exec veep and chief operating officer, and former Tornier (NSDQ:TRNX) CEO, David Mowry will be stepping down from the company on May 6 to pursue other opportunities. The company did not indicate who would take Mowry’s position. Read more
Medtronic touts 7-year follow-up data on 2-level Prestige LP disc
Medtronic (NYSE:MDT) today released 7-year follow-up data from a study of its 2-level Prestige LP cervical disc, touting favorable clinical outcomes and patient satisfaction with the system. Medtronic touts the study as the longest patient follow-up data ever for U.S. 2-level cervical disc patients. The data was presented at the 84th Annual Meeting of the American […]
UnitedHealth names Medtronic as preferred insulin pump vendor, dealing blows to Tandem, Insulet, DexCom
Update: Updated with analyst information on Insulet and DexCom, and Insulet’s response. Tandem Diabetes Care (NSDQ:TNDM) shares dropped over 20% after UnitedHealth Group (NYSE:UNH) announced it is making Medtronic (NYSE:MDT) its preferred provider of insulin pumps. Insulet (NSDQ:PODD) and Dexcom Inc. (NSDQ:DXCM) also took a hit with the news, seeing shares drop 10% and 3% respectively The shift will go into […]
Medtronic wins FDA clearance for StrataMR valves
Medtronic (NYSE:MDT) today said it won FDA clearance for its StrataMR valves and shunts for patients with hydrocephalus and cerebrospinal fluid conditions. The clearance allows the valves and shunts to be used during MRI scans at their performance level setting at up to 3.0 Tesla, Fridley, Minn.-based Medtronic said. StrataMR is slated to be available “in the […]
FDA approves afib-detecting Visia ICD from Medtronic
Medtronic (NYSE:MDT) said it won FDA approval for its Visia AF line of implantable cardioverter defibrillators, which are designed to detect and monitor atrial fibrillation symptoms. Fridley, Minn.-based Medtronic said it plans to have the Visia AF MRI SureScan and Visia AF single-chamber ICDs on the market in early summer. The devices won CE Mark approval in the European Union […]
Medtronic, Masimo split win in PTAB decision
Masimo (NSDQ:MASI) said this week the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board delivered split a decision related to pulse oximetry technology patents owned by Masimo that were challenged last year by Medtronic (NYSE:MDT). The PTAB ruled on petitions to review 2 different patents owned by Masimo related to signal processing apparati, granting Medtronic’s […]
Medtronic touts VenaSeal data
Medtronic (NYSE:MDT) today released clinical data from a study of its VenaSeal closure system, claiming consistent long-term durability and improved quality of life in patients with venous reflux disease treated with the system The VenaSeal system from the Fridley, Minn.-based medical giant uses a proprietary medical adhesive to close superficial veins in lower extremities in patients […]
